|
2025-04-04 |
2025-04-02 |
V
Vente
|
Ferguson Toby
Chief Medical Officer
Dirigeant
|
10 086
-6.0%
3,43
34 595 USD
|
10 086
-6.0%
|
3,43
|
34 595 USD
|
|
|
2025-04-04 |
2025-04-02 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
10 885
-2.5%
3,43
37 336 USD
|
10 885
-2.5%
|
3,43
|
37 336 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
3 305
-4.1%
4,26
14 079 USD
|
3 305
-4.1%
|
4,26
|
14 079 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
11 702
-3.8%
4,24
49 616 USD
|
11 702
-3.8%
|
4,24
|
49 616 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
3 894
-3.8%
4,25
16 550 USD
|
3 894
-3.8%
|
4,25
|
16 550 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
6 950
-6.4%
4,45
30 928 USD
|
6 950
-6.4%
|
4,45
|
30 928 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
5 413
-6.3%
4,45
24 088 USD
|
5 413
-6.3%
|
4,45
|
24 088 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Sandrock Alfred
President & CEO
Dirigeant
|
16 644
-5.1%
4,45
74 066 USD
|
16 644
-5.1%
|
4,45
|
74 066 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Dirigeant
|
4 358
-5.1%
4,45
19 393 USD
|
4 358
-5.1%
|
4,45
|
19 393 USD
|
|
|
2025-01-15 |
2025-01-14 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
1 191
-1.4%
5,13
6 110 USD
|
1 191
-1.4%
|
5,13
|
6 110 USD
|
|
|
2025-01-15 |
2025-01-14 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
3 087
-2.7%
5,09
15 713 USD
|
3 087
-2.7%
|
5,09
|
15 713 USD
|
|
|
2024-12-26 |
2024-12-23 |
VP
Vente planifiée
|
Swartz Robin
COO&CBO
Dirigeant
|
6 500
-5.5%
5,65
36 725 USD
|
6 500
-5.5%
|
5,65
|
36 725 USD
|
|
|
2024-10-03 |
2024-10-02 |
V
Vente
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Dirigeant
|
5 999
-6.5%
5,82
34 914 USD
|
5 999
-6.5%
|
5,82
|
34 914 USD
|
|
|
2024-04-03 |
2024-04-02 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
12 115
-3.6%
9,86
119 454 USD
|
12 115
-3.6%
|
9,86
|
119 454 USD
|
|
|
2024-04-03 |
2024-04-02 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
1 357
-1.1%
9,88
13 407 USD
|
1 357
-1.1%
|
9,88
|
13 407 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
13 033
-3.7%
7,46
97 226 USD
|
13 033
-3.7%
|
7,46
|
97 226 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
3 764
-2.1%
7,46
28 079 USD
|
3 764
-2.1%
|
7,46
|
28 079 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
3 365
-3.7%
7,47
25 137 USD
|
3 365
-3.7%
|
7,47
|
25 137 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
3 966
-3.2%
7,45
29 547 USD
|
3 966
-3.2%
|
7,45
|
29 547 USD
|
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
602
-0.7%
7,68
4 623 USD
|
602
-0.7%
|
7,68
|
4 623 USD
|
|
|
2024-01-19 |
2024-01-17 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
1 266
-2.3%
7,18
9 090 USD
|
1 266
-2.3%
|
7,18
|
9 090 USD
|
|
|
2024-01-19 |
2024-01-17 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
2 543
-3.4%
7,15
18 182 USD
|
2 543
-3.4%
|
7,15
|
18 182 USD
|
|
|
2023-10-05 |
2023-10-03 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
13 567
-8.3%
6,99
94 833 USD
|
13 567
-8.3%
|
6,99
|
94 833 USD
|
|
|
2023-09-18 |
2023-09-15 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
10 500
-16.2%
8,16
85 680 USD
|
10 500
-16.2%
|
8,16
|
85 680 USD
|
|
|
2023-07-10 |
2023-07-06 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
5 500
-8.4%
10,80
59 400 USD
|
5 500
-8.4%
|
10,80
|
59 400 USD
|
|
|
2023-07-05 |
2023-06-30 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
5 000
-7.1%
11,41
57 050 USD
|
5 000
-7.1%
|
11,41
|
57 050 USD
|
|
|
2023-04-05 |
2023-04-03 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
1 259
-1.7%
7,83
9 858 USD
|
1 259
-1.7%
|
7,83
|
9 858 USD
|
|
|
2023-04-05 |
2023-04-03 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
7 437
-3.3%
7,83
58 232 USD
|
7 437
-3.3%
|
7,83
|
58 232 USD
|
|
|
2023-03-22 |
2023-03-20 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
2 193
-3.2%
7,76
17 018 USD
|
2 193
-3.2%
|
7,76
|
17 018 USD
|
|
|
2023-03-22 |
2023-03-20 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
4 410
-4.1%
7,76
34 222 USD
|
4 410
-4.1%
|
7,76
|
34 222 USD
|
|
|
2023-03-22 |
2023-03-20 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
3 654
-4.8%
7,76
28 355 USD
|
3 654
-4.8%
|
7,76
|
28 355 USD
|
|
|
2023-03-17 |
2023-03-15 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
15 373
-16.7%
8,20
126 059 USD
|
15 373
-16.7%
|
8,20
|
126 059 USD
|
|
|
2023-02-24 |
2023-02-23 |
A
Achat
|
NEUROCRINE BIOSCIENCES INC
Actionnaire important
|
4 395 588
+105.2%
8,88
39 032 821 USD
|
4 395 588
+105.2%
|
8,88
|
39 032 821 USD
|
|
|
2023-02-22 |
2023-02-17 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
3 297
-3.0%
7,45
24 563 USD
|
3 297
-3.0%
|
7,45
|
24 563 USD
|
|
|
2023-02-22 |
2023-02-17 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
738
-1.1%
7,45
5 498 USD
|
738
-1.1%
|
7,45
|
5 498 USD
|
|
|
2023-02-15 |
2023-02-13 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
797
-2.3%
7,67
6 113 USD
|
797
-2.3%
|
7,67
|
6 113 USD
|
|
|
2023-02-15 |
2023-02-13 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
2 868
-2.5%
7,67
21 998 USD
|
2 868
-2.5%
|
7,67
|
21 998 USD
|
|
|
2023-02-01 |
2023-02-01 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
128 642
-2.7%
9,32
1 198 943 USD
|
128 642
-2.7%
|
9,32
|
1 198 943 USD
|
|
|
2023-02-01 |
2023-01-31 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
185 000
-3.7%
9,25
1 711 250 USD
|
185 000
-3.7%
|
9,25
|
1 711 250 USD
|
|
|
2023-02-01 |
2023-01-30 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
75 000
-1.5%
9,03
677 250 USD
|
75 000
-1.5%
|
9,03
|
677 250 USD
|
|
|
2023-01-31 |
2023-01-27 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
50 000
-1.0%
9,02
451 000 USD
|
50 000
-1.0%
|
9,02
|
451 000 USD
|
|
|
2023-01-26 |
2023-01-25 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
50 000
-1.0%
9,22
461 000 USD
|
50 000
-1.0%
|
9,22
|
461 000 USD
|
|
|
2023-01-26 |
2023-01-24 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
100 000
-1.9%
9,27
927 000 USD
|
100 000
-1.9%
|
9,27
|
927 000 USD
|
|
|
2023-01-24 |
2023-01-23 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
55 000
-1.0%
9,06
498 300 USD
|
55 000
-1.0%
|
9,06
|
498 300 USD
|
|
|
2023-01-24 |
2023-01-20 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
100 000
-1.8%
9,15
915 000 USD
|
100 000
-1.8%
|
9,15
|
915 000 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
792
-0.7%
10,34
8 189 USD
|
792
-0.7%
|
10,34
|
8 189 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
1 396
-1.2%
9,57
13 360 USD
|
1 396
-1.2%
|
9,57
|
13 360 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
792
-1.5%
10,34
8 189 USD
|
792
-1.5%
|
10,34
|
8 189 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
1 396
-2.6%
9,57
13 360 USD
|
1 396
-2.6%
|
9,57
|
13 360 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
400
-1.1%
10,34
4 136 USD
|
400
-1.1%
|
10,34
|
4 136 USD
|
|
|
2023-01-19 |
2023-01-17 |
VP
Vente planifiée
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
706
-2.0%
9,57
6 756 USD
|
706
-2.0%
|
9,57
|
6 756 USD
|
|
|
2023-01-11 |
2023-01-11 |
V
Vente
|
EcoR1 Capital, LLC
Actionnaire important
|
110 000
-2.8%
8,50
934 615 USD
|
110 000
-2.8%
|
8,50
|
934 615 USD
|
|
|
2023-01-11 |
2023-01-10 |
V
Vente
|
EcoR1 Capital, LLC
Actionnaire important
|
336 400
-7.8%
8,05
2 709 433 USD
|
336 400
-7.8%
|
8,05
|
2 709 433 USD
|
|
|
2023-01-11 |
2023-01-09 |
V
Vente
|
EcoR1 Capital, LLC
Actionnaire important
|
456 000
-9.6%
7,67
3 498 295 USD
|
456 000
-9.6%
|
7,67
|
3 498 295 USD
|
|
|
2023-01-10 |
2023-01-06 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
388
-1.1%
6,41
2 487 USD
|
388
-1.1%
|
6,41
|
2 487 USD
|
|
|
2022-08-26 |
2022-08-25 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
200 000
-3.6%
6,22
1 244 000 USD
|
200 000
-3.6%
|
6,22
|
1 244 000 USD
|
|
|
2022-08-26 |
2022-08-24 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
149 972
-2.6%
6,09
913 329 USD
|
149 972
-2.6%
|
6,09
|
913 329 USD
|
|
|
2022-08-18 |
2022-08-16 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
128 456
-2.2%
6,04
775 874 USD
|
128 456
-2.2%
|
6,04
|
775 874 USD
|
|
|
2022-08-16 |
2022-08-15 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
135 808
-2.2%
6,04
820 280 USD
|
135 808
-2.2%
|
6,04
|
820 280 USD
|
|
|
2022-08-16 |
2022-08-12 |
V
Vente
|
Third Rock Ventures III, L.P.
Actionnaire important
|
348 007
-5.4%
6,12
2 129 803 USD
|
348 007
-5.4%
|
6,12
|
2 129 803 USD
|
|
|
2022-07-18 |
2022-07-14 |
VP
Vente planifiée
|
PIERCE GLENN
Administrateur non-exécutif
|
9 512
-36.2%
6,70
63 730 USD
|
9 512
-36.2%
|
6,70
|
63 730 USD
|
|
|
2022-07-18 |
2022-07-14 |
VP
Vente planifiée
|
Higgins Michael J
Administrateur non-exécutif
|
13 891
-30.7%
6,70
93 070 USD
|
13 891
-30.7%
|
6,70
|
93 070 USD
|
|
|
2022-06-23 |
2022-06-23 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
376 000
+8.6%
5,66
2 126 543 USD
|
376 000
+8.6%
|
5,66
|
2 126 543 USD
|
|
|
2022-06-23 |
2022-06-21 |
A
Achat
|
EcoR1 Capital, LLC
Actionnaire important
|
101 400
+2.4%
5,28
535 504 USD
|
101 400
+2.4%
|
5,28
|
535 504 USD
|
|
|
2022-04-06 |
2022-04-04 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
1 527
-2.8%
8,25
12 598 USD
|
1 527
-2.8%
|
8,25
|
12 598 USD
|
|
|
2022-04-06 |
2022-04-04 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
2 786
-2.4%
8,25
22 985 USD
|
2 786
-2.4%
|
8,25
|
22 985 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
51
-0.1%
8,68
443 USD
|
51
-0.1%
|
8,68
|
443 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
4 362
-7.5%
8,29
36 161 USD
|
4 362
-7.5%
|
8,29
|
36 161 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Burek Julie
VP, Finance
Dirigeant
|
31
-0.1%
8,68
269 USD
|
31
-0.1%
|
8,68
|
269 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Burek Julie
VP, Finance
Dirigeant
|
2 618
-4.8%
8,29
21 703 USD
|
2 618
-4.8%
|
8,29
|
21 703 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
58
-0.0%
8,68
503 USD
|
58
-0.0%
|
8,68
|
503 USD
|
|
|
2022-03-23 |
2022-03-21 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
4 897
-4.0%
8,29
40 596 USD
|
4 897
-4.0%
|
8,29
|
40 596 USD
|
|
|
2022-02-22 |
2022-02-17 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
4 100
-3.2%
3,55
14 555 USD
|
4 100
-3.2%
|
3,55
|
14 555 USD
|
|
|
2022-02-22 |
2022-02-17 |
VP
Vente planifiée
|
Burek Julie
VP, Finance
Dirigeant
|
789
-1.4%
3,55
2 801 USD
|
789
-1.4%
|
3,55
|
2 801 USD
|
|
|
2022-02-15 |
2022-02-11 |
VP
Vente planifiée
|
Hesslein Robert W.
Senior VP & General Counsel
Dirigeant
|
3 252
-2.5%
3,36
10 927 USD
|
3 252
-2.5%
|
3,36
|
10 927 USD
|
|
